• Aucun résultat trouvé

18 résultats avec le mot-clé: 'b cell'

The novel TORC1/2 kinase inhibitor PQR620 has anti-tumor activity in lymphomas as a single agent and in combination with venetoclax

DLBCL, diffuse large B-cell lymphoma; ABC-DLBCL, activated B-cell like diffuse large B-cell lymphoma; GCB-DLBCL, germinal center B-cell type diffuse large B-cell lymphoma; MCL,

Protected

N/A

12
0
0
2021
Naturally improving the natural cytotoxicity of natural killer (NK) cells

Abbreviations: ADCC, antibody-dependent cell-mediated cytotoxicity; AML, acute myeloid leukemia; B-CLL, B-cell chronic lymphocytic leukemia; B-NHL, B-cell non-Hodgkin’s lymphoma;

Protected

N/A

11
0
0
2021
State-of-the-art for CAR T-cell therapy for chronic lymphocytic leukemia in 2019

B-ALL: B-cell acute lymphoblastic leukemia; BCL2: B-cell lymphoma 2; BCR: B- cell receptor; BTK: Bruton Tyrosine Kinase; CAR T cells: T-cell with chimeric antigen receptor; CLL:

Protected

N/A

6
0
0
2021
Implication of immune system in chondrosarcoma progression and therapeutic response : Could immunotherapy play a role in chondrosarcoma treatment ?

ATP binding cassette subfamily B member 1 Adoptive cell transfer Antigen presenting cell B-cell lymphoma 2 B-cell lymphoma-extra large Cluster of differentiation Chondrosarcoma

Protected

N/A

198
0
0
2021
Impact of B cell/lymphoid stromal cell crosstalk in B-cell physiology and malignancy

Lymphoid stromal cells form a heterogeneous and plastic cell compartment Follicular and extrafollicular stromal cells contribute to normal B-cell activation FL-CAFs exhibit

Protected

N/A

23
0
0
2021
Disturbance of cytokine networks in Sjögren's syndrome.

APRIL, a proliferation-inducing ligand; BAFF, B-cell-activating factor; BCR, B cell antigen receptor; Be, B eff ector; Breg, regulatory B; DC, dendritic cell; GC, germinal center;

Protected

N/A

11
0
0
2021
Subversion of the B-cell compartment during parasitic, bacterial, and viral infections

Ab: Antibody; Ag: Antigen; BAFF: B cell –Activating Factor belonging to the TNF Family; BCR: B-Cell Receptor; B-reg: Regulatory B-cells; DC: Dendritic Cell; EBV: Epstein –Barr

Protected

N/A

11
0
0
2021
Impact des composantes cellulaires de la leucémie lymphoïde chronique de type B dans les rechutes post-thérapeutiques : de la Side population leucémique aux cellules immunitaires

TITLE: Impact of B-cell Chronic Lymphocytic Leukemia cell components in post- therapeutic relapses : from leukemic chemoresistant Side Population to immune cells. B-cell

Protected

N/A

189
0
0
2021
en
                                                                    fr

Autoreactive B cell receptors mimic autonomous pre-B cell receptor signaling and induce proliferation of early B cells.. Autophagy and the integrated

Protected

N/A

210
0
0
2021
Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies.

ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; B-ALL, B-cell acute lymphoblastic leukemia; BAT, Bispecific antibody armed activated T-cells; BCMA, B-cell

Protected

N/A

20
0
0
2021
Early expression of Ig μ chain from a transgene significantly reduces the duration of the pro-B stage but does not affect the small pre-B stage

Early expression of the n chain from the transgene significantly reduced the duration of the pro-B cell stage but did not affect the small pre-B cell stage B cell development

Protected

N/A

10
0
0
2021
Allergy : a new role for T cell superantigens of Staphylococcus aureus?

The activated SAg-specific T cells will provide T cell help to the presenting B cells, resulting in B cell activation, plasma cell differentiation, and the release of

Protected

N/A

21
0
0
2022
Chronic viral infection promotes efficient germinal center B cell responses

Chronic Infection Triggers a Sustained GC Response with Prolonged Plasma Cell and Memory B Cell Output To compare the generation and maintenance of B cell responses in chronic and

Protected

N/A

23
0
0
2022
Somatic mutations of cell-free circulating DNA detected by Next Generation Sequencing reflect the genetic changes in both Germinal Center B-Cell like and Activated B-Cell like Diffuse Large B-Cell Lymphoma tumors at the time of diagnosis

Somatic mutations of cell-free circulating DNA detected by Next Generation Sequencing reflect the genetic changes in both Germinal Center B-Cell like and Activated B-Cell like

Protected

N/A

22
0
0
2021
Immunophenotyping without antibodies : New perspectives for lymphoma characterization
			
			  
			    = Immunphänotypisierung ohne Antikörper : Neue Perspektiven in der Lymphomcharakterisierung

Four HL cell lines of nodular sclerosing and mixed cellularity type, four diffuse large B cell lymphoma (DLBCL) lines of ger­ minal centre and activated cell type and a

Protected

N/A

3
0
0
2021
Nombre de nouveaux caspour 100 000 habitants/an

B-cell lymphoma, unclassifiable, with features intermediate between DLBCL and Burkitt lymphoma. B-cell lymphoma, unclassifiable, with features intermediate between DLBCL

Protected

N/A

83
0
0
2022
Gene expression profiles during beta cell maturation and after IL-1beta exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1beta sensitivity

Transcript changes not affected during beta cell maturation but only after IL-1β exposure of the pre-beta-cell phenotype (group B, Table B, web address), the beta cell phenotype

Protected

N/A

16
0
0
2022
Vésicules extracellulaires de Staphylococcus aureus. Composition et rôle en contexte mammite

protein 1 Regulated on activation, normal T cell expressed and secreted. B-cell

Protected

N/A

32
0
0
2021

Télécharger plus de documents et télécharger des études de documentation immédiatement !